Adnan Yousaf, MD
Interventional Cardiology · Davenport, IANPI 1306324975
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 46.5% of the total. Reporting peaked in 2023 at $2,532 and has fallen 57.2% since, to $1,085 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IA, where the typical reported total is $3,872.
Across 37 payments — averaging $104.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$985
- Abbott$189
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$155
- Kiniksa Pharmaceuticals, Ltd.$123
- Abiomed$120
- plus $501 from 7 others
What the payments were for
- Grants$2948%
- Travel & lodging$1,27633%
- Food & beverage$1,97251%
- Education$3309%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $1,799 |
| Boston Scientific | 4 | $985 |
| Abbott | 2 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $155 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $123 |
| Abiomed | 4 | $120 |
| Penumbra, Inc. | 2 | $111 |
| Cordis US CORP. | 1 | $102 |
| Cardiva Medical, Inc. | 1 | $85 |
| Cathworks, Inc. | 1 | $84 |
| Chiesi USA, Inc. | 1 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ClosureFast$971
- ONYX FRONTIER$331
- ENSITE$175
- ARCALYST$123
- COREVALVE EVOLUT R$104
- HawkOne$103
- MYNX CONTROL$102
How this compares
$3,872 in reported general payments places this provider in the 50th percentile of 64 interventional cardiology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $33,190 |
| Metoprolol Succinate | 78 | $850 |
| Rosuvastatin Calcium | 26 | $496 |
| Atorvastatin Calcium | 42 | $346 |
| Lisinopril | 41 | $261 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 29 | $250 |
| ClopidogrelClopidogrel Bisulfate | 30 | $176 |
| Carvedilol | 18 | $173 |
| Losartan Potassium | 21 | $156 |
| Furosemide | 47 | $152 |
| Nitroglycerin | 19 | $141 |
| Metoprolol Tartrate | 15 | $73 |
| Amlodipine Besylate | 27 | $72 |
| Warfarin Sodium | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Davenport
- Nicolas ShammasDavenport$808K
- Eric DippelDavenport$100K
- Srikanth KasulaDavenport$43K
- Devika KirDavenport$11K
- Amit BahiaDavenport$8K
- Parth DesaiDavenport$5K
- Atul ChawlaDes Moines$78K
- Magdi GhaliWest Des Moines$64K
- David McAllisterDes Moines$55K
- Daniel ShivapourDes Moines$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.